- Home
- ATYR vs BROG Comparison
ATYR vs BROG Comparison
Compare ATYR & BROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- BROG
- Stock Information
- Founded
- ATYR 2005
- BROG 2019
- Country
- ATYR United States
- BROG United Arab Emirates
- Employees
- ATYR N/A
- BROG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- BROG Integrated oil Companies
- Sector
- ATYR Health Care
- BROG Energy
- Exchange
- ATYR Nasdaq
- BROG Nasdaq
- Market Cap
- ATYR 126.3M
- BROG 114.0M
- IPO Year
- ATYR 2015
- BROG N/A
- Fundamental
- Price
- ATYR $1.87
- BROG $1.55
- Analyst Decision
- ATYR Strong Buy
- BROG
- Analyst Count
- ATYR 4
- BROG 0
- Target Price
- ATYR $19.25
- BROG N/A
- AVG Volume (30 Days)
- ATYR 454.0K
- BROG 58.4K
- Earning Date
- ATYR 11-07-2024
- BROG 10-18-2024
- Dividend Yield
- ATYR N/A
- BROG N/A
- EPS Growth
- ATYR N/A
- BROG 174.67
- EPS
- ATYR N/A
- BROG 0.69
- Revenue
- ATYR $588,000.00
- BROG $116,053,731.00
- Revenue This Year
- ATYR N/A
- BROG N/A
- Revenue Next Year
- ATYR $2,057.88
- BROG N/A
- P/E Ratio
- ATYR N/A
- BROG $2.25
- Revenue Growth
- ATYR N/A
- BROG 161.86
- 52 Week Low
- ATYR $1.08
- BROG $0.80
- 52 Week High
- ATYR $2.50
- BROG $6.66
- Technical
- Relative Strength Index (RSI)
- ATYR 55.26
- BROG 58.15
- Support Level
- ATYR $1.67
- BROG $1.37
- Resistance Level
- ATYR $1.81
- BROG $1.69
- Average True Range (ATR)
- ATYR 0.08
- BROG 0.19
- MACD
- ATYR 0.00
- BROG -0.01
- Stochastic Oscillator
- ATYR 68.97
- BROG 58.62
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About BROG Brooge Energy Limited
Brooge Energy Ltd is an Oil Refinery & Storage Company in the United Arab Emirates. The company generates revenue from the leasing of storage capacity of tanks and other ancillary services.